Follow-The-Filings

Security · featured owners

IRD

Opus Genetics Inc. COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.4%
  • $5M
  • 1 add 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (James Silverman - Opaleye...) · not free-float ownership

  1. James Silverman add 0.4%

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 0.4% Add +0.4% 1,125,000 $5M hist
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0.03% Exit −0.03 pp 1,000,000 $5M hist

1 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $19.05M $10.99M $14.2M
Gross profit — — —
Gross margin — — —
Net income -$9.99M -$57.53M -$49.59M
Net margin * -52.4% -523.4% -349.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $53.95M $36.61M $50.04M
Total non-current assets * $0.00 $252,000 $199,000
Total assets $53.95M $36.86M $50.24M
Total current liabilities $4.04M $11.3M $7.78M
Total non-current liabilities * $0.00 $0.00 $27.11M
Total equity $49.91M $6.72M $15.35M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.11M -$25.58M -$35.25M
Cash from investing $0.00 $1.21M $0.00
Cash from financing $8.98M $4.19M $50.02M
Net change in cash * $7.87M -$20.18M $14.77M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders